FDA Seeks Risk-Based Inspection Program

FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.

Related Content:

Regulatory WatchPharmaceutical Technology-11-02-2003

FDA Joins Effort to Curb Drug Patent Abuses

Gamesmanship Escalates over FDA User Fee Legislation

FDA Advances Quality Initiatives to Combat Drug Shortages